Hong Kong Stock Movement | Wangshan Wangshui-B (02630.HK) rose over 4% in the afternoon; the Class 1 new antipsychotic drug VV119 recently entered Phase II clinical trials.

Zhito Finance APP has learned that VastSummit Pharma-B (02630.HK) rose more than 4% in the afternoon. As of press time, it was up 4.63%, at HK$84.7, with a turnover of HK$6.8314 million.